Mucosal vaccines: wisdom from now and then. (26th August 2021)

• Record Type: Journal Article
• Authors: Kiyono, Hiroshi; Yuki, Yoshikazu; Nakahashi-Ouchida, Rika; Fujihashi, Kohtaro
• Is Part Of: International immunology. Volume 33:Number 12(2021)
• Page Start: 767
• Page End: 774
• Publication Date: 2021-08-26
• Subjects: delivery system -- infectious disease -- MucoRice -- nanogel -- SIgA; Immunology -- Periodicals; 616.079
• DOI: 10.1093/intimm/dxab056
• Languages: English
• ISSNs: 0953-8178

Abstract

Abstract: The oral and nasal cavities are covered by the mucosal epithelium that starts at the beginning of the aero-digestive tract. These mucosal surfaces are continuously exposed to environmental antigens including pathogens and allergens and are thus equipped with a mucosal immune system that mediates initial recognition of pathogenicity and initiates pathogen-specific immune responses. At the dawn of our scientific effort to explore the mucosal immune system, dental science was one of the major driving forces as it provided insights into the importance of mucosal immunity and its application for the control of oral infectious diseases. The development of mucosal vaccines for the prevention of dental caries was thus part of a novel approach that contributed to building the scientific foundations of the mucosal immune system. Since then, mucosal immunology and vaccines have gone on a scientific journey to become one of the major entities within the discipline of immunology. Here, we introduce our past and current efforts and future directions for the development of mucosal vaccines, specifically a rice-based oral vaccine (MucoRice) and a nanogel-based nasal vaccine, with the aim of preventing and controlling gastrointestinal and respiratory infectious diseases using the interdisciplinary fusion of mucosal immunology with agricultural science and biomaterial engineering, respectively.